Not logged in Share Save
Share Save
Share Save
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial Ahn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia Share Save
Share Save
Share Save
Share Save
Share Save
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC An Open-Label Phase 2 Trial (ILLUMINATE) Lee, Chee Khoon; Liao, Bin-Chi; Subramaniam, Shalini; Chiu, Chao-Hua; Mersiades, Antony; Ho, Chao-Chi; Brown, Chris; Lai, Chun-Liang; Hughes, Brett G. M.; Yang, Tsung-Ying; O'Byrne, Ken; Luo, Yung-Hung; Yip, Sonia; Ho, Ching-Liang; Bray, Victoria; Su, Wu-Chou; Moore, Melissa; Feng, Wei-Lien; Bai, Ya-Ying; Ford, Kate; Cummins, Michelle M.; Stockler, Martin R.; Solomon, Benjamin J.; John, Thomas; Yang, James Chih-Hsin Share Save
Doxorubicin synergizes bortezomib-induced multiple myeloma cell death by inhibiting aggresome formation and augmenting endoplasmic reticulum/Golgi stress and apoptosis Yu, Chang-Tze Ricky; Liao, Yu-Ting Amber; Chiang, Chi-Yin Nina; Chen, Jo-Mei Maureen; Pan, Hsin-Yu Bella; Pan, Chia-Yun; Jiang, Wei-Jun; Tsai, Jia-Rung; Yang, Tsung-Ying; Teng, Chieh-Lin Jerry Share Save
FLAURA2: exploratory analysis of baseline (BL) and on-treatment plasma EGFRm dynamics in patients (pts) with EGFRm advanced NSCLC treated with first-line (1L) osimertinib (osi) ± platinum-pemetrexed Janne, Pasi A.; Kobayashi, Kunihiko; Robichaux, Jacqulyne; Lee, Chee Khoon; Sugawara, Shunichi; Yang, Tsung-Ying; Kim, Tae Min; Yanagitani, Noriko; Kim, Sang-We; Markovets, Aleksandra; Bhetariya, Preetida; Poole, Lynne; Ghiorghiu, Dana; Hartmaier, Ryan; Yang, James Chih-Hsin; Planchard, David Share Save
Share Save
Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib Wu, Jia-Jun; Tseng, Jeng-Sen; Zheng, Zhe-Rong; Chu, Cheng-Hsiang; Chen, Kun-Chieh; Lin, Mong-Wei; Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Yang, Tsung-Ying; Yu, Sung-Liang; Chen, Jin-Shing; Ho, Chao-Chi; Chang, Gee-Chen Share Save
Share Save
Share Save
An open-label, first-in-human study of BAY2927088 in patients with advanced non-small cell lung cancer (NSCLC) harboring an EGFR and/or HER2 mutation Tan, Daniel; Goto, Koichi; Loong, Herbert Hf; Yang, Tsung-Ying; Gadgeel, Shirish; Massarelli, Erminia; Daniele, Gennaro; Le, Xiuning; Shinno, Yuki; Murakami, Haruyasu; Sakamoto, Tomohiro; Ruffinelli, Jose C.; Lu, Shun; Zhang, Yiping; Kim, Tae Min; Brennan, Barbara J.; Chen, Chunlin; Joosten, Miranda; Wang, Zebin; Pu, Su-Fen; Bao, Weichao; Kornacker, Martin; Ferraldeschi, Roberta; Grassi, Paolo; Goh, Boon Cher Share Save
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma Lee, Po-Hsin; Chiang, Chun-Ju; Tseng, Jeng-Sen; Zheng, Zhe-Rong; Chen, Kun-Chieh; Chu, Cheng-Hsiang; Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Lee, Wen-Chung; Yang, Tsung-Ying; Liu, Tsang-Wu; Hsia, Jiun-Yi; Chang, Gee-Chen Share Save
Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment Lee, Po-Hsin; Huang, Yen-Hsiang; Hsu, Yu-Wei; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Lin, Ho; Lee, Teng-Yu; Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying Share Save
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan (vol 17, pg 295, 2022) Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; Yu, Sung-Liang; Chen, Jeremy J. W.; Chang, Gee-Chen Share Save
Involvement of a BH3-only apoptosis sensitizer gene Blm-s in hippocampus-mediated mood control Huang, Pei-Hsin; Yang, Tsung-Ying; Yeh, Chia-Wei; Huang, Sheng-Min; Chang, Ho-Ching; Hung, Yun-Fen; Chu, Wen-Chia; Cho, Kuan-Hung; Lu, Tzu-Pin; Kuo, Po-Hsiu; Lee, Li-Jen; Kuo, Li-Wei; Lien, Cheng-Chang; Cheng, Hwai-Jong Share Save